Shopping Cart
- Remove All
Your shopping cart is currently empty
ERK1/2 inhibitor 1 is a potent, orally bioavailable compound that exhibits 60% inhibition at 1 nM and has an IC50 of 3.0 nM against ERK1 and ERK2, respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $128 | In Stock | |
| 5 mg | $322 | In Stock | |
| 10 mg | $465 | In Stock | |
| 25 mg | $713 | In Stock | |
| 50 mg | $953 | In Stock | |
| 100 mg | $1,300 | In Stock |
| Description | ERK1/2 inhibitor 1 is a potent, orally bioavailable compound that exhibits 60% inhibition at 1 nM and has an IC50 of 3.0 nM against ERK1 and ERK2, respectively. |
| Targets&IC50 | ERK2:3.0 nM, ERK1: |
| In vitro | ERK1/2 inhibitor 1 ?shows excellent antiproliferative potency with IC50s of 7.5 and 4.9 nM in ?Colo205 cells and A375, respectively. |
| Molecular Weight | 550.05 |
| Formula | C29H32ClN5O4 |
| Cas No. | 2095719-90-5 |
| Smiles | C[C@@H](N1Cc2ccc(cc2C1=O)-c1nc(NC2CCOCC2)ncc1Cl)C(=O)N[C@H](CO)c1cccc(C)c1 |
| Relative Density. | 1.344 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 5.5 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (1.82 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.